{"nct_id":"NCT03039114","title":"Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102)","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2017-02-15","start_date_type":"ACTUAL","primary_completion_date":"2021-03-30","primary_completion_date_type":"ACTUAL","completion_date":"2021-03-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["INCY"]}